Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-026991 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-03 | 2023-05-02 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale | $348.28 | -580 | 4,691 | -11% | -$202.0K |
| 2023-05-03 | 2023-05-01 | VRTX | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +1,168 | 5,208 | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-02 | S | D | 172 | $346.69 | 4,974 | D | — | — | (F3) Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03). |
| 2 | Common | Common Stock | 2023-05-02 | S | D | 120 | $348.16 | 4,854 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64). (F3) Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-05-01 | A | A | 1,168 | $0.00 | 5,208 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 4 | Common | Common Stock | 2023-05-02 | S | D | 62 | $345.93 | 5,146 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12). (F3) Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-05-02 | S | D | 63 | $351.20 | 4,628 | D | — | — | (F8) Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48). (F3) Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2023-05-02 | S | D | 163 | $349.82 | 4,691 | D | — | — | (F7) Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08). (F3) Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |